Skip to main content
ABSI logo

Absci Corporation

ABSINASDAQHealthcareBiotechnology

$8.25Today:- (-)1Y +96.03%

As of Oct 16, 2026 close

Market cap
$1.40B
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$2.24$12.06
Volume (live)
-
Avg. volume (3M)
4.02M

Absci (ABSI) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Absci reported total assets of $216.30M and total liabilities of $26.85M. Shareholders' equity was $189.45M, up 5.8% from $179.13M a year earlier. Total debt stood at $5.30M against $144.29M in cash and short-term investments, a net cash position of $138.99M. That puts debt-to-equity at 0.03, compared with 0.06 a year earlier.

Absci Balance Sheet Analysis

Values in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Absci Corporation (ABSI) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
Current Assets
Cash and Cash Equivalents20.0341.2172.3659.96252.5769.8713.09
Short-Term Investments124.2771.2125.30104.480.000.000.00
Cash & Short-Term Investments144.29112.4397.66164.43252.5769.8713.09
Accounts Receivable0.000.002.191.551.431.590.22
Inventory0.000.000.0015.0210.510.000.00
Other Current Assets5.2821.4120.735.868.571.770.34
Total Current Assets149.57133.83120.58186.86273.0873.2313.65
Non-Current Assets
Property, Plant & Equipment (Net)23.7733.1445.8258.0458.6513.395.01
Long-Term Investments0.000.000.001.8616.840.000.79
Goodwill0.000.000.0021.3421.340.000.00
Intangible Assets41.5144.8848.2551.6254.990.000.28
Other Non-Current Assets1.441.762.65-16.3818.141.950.53
Total Non-Current Assets66.7279.7896.72134.15153.1215.345.82
Total Assets216.30213.61217.30321.01426.2088.5719.47
Current Liabilities
Accounts Payable19.353.531.502.418.392.120.27
Short-Term Debt2.684.423.266.936.690.901.89
Current Portion of Long-Term Debt0.872.733.262.952.400.90-
Accrued Liabilities16.596.846.5520.4817.431.57-
Deferred Revenue0.741.123.170.451.352.630.78
Other Current Liabilities16.5919.5912.7520.4817.434.200.53
Total Current Liabilities22.7728.6629.5630.2733.8610.103.47
Non-Current Liabilities
Long-Term Debt2.625.694.6616.0513.324.144.13
Deferred Tax Liabilities0.000.000.190.240.740.000.00
Other Non-Current Liabilities1.460.131.260.0412.160.7553.03
Total Non-Current Liabilities4.085.8211.5616.3226.2311.4757.16
Total Liabilities26.8534.4841.1246.5960.0921.5660.63
Stockholders' Equity
Common Stock0.020.010.010.010.010.000.00
Retained Earnings-624.78-509.60-406.50-295.93-191.03-90.07-41.38
Accumulated Other Comprehensive Income0.590.00-0.04-0.12-0.010.00-52.76
Additional Paid-in Capital813.63688.73582.70570.45557.140.630.22
Shares Outstanding151.52115.3693.0992.4192.65--
Total Stockholders' Equity189.45179.13176.18274.41366.1167.01-41.16
Total Liabilities & Equity216.30213.61217.30321.01426.2088.5719.47

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Absci Balance Sheet

How much debt does Absci have?

Absci had total debt of $5.30M as of Dec 31, 2025, against $144.29M in cash and short-term investments. Its debt-to-equity ratio was 0.03. Total debt was $10.11M a year earlier.

What are Absci's total assets?

Absci reported total assets of $216.30M as of Dec 31, 2025, up 1.3% from $213.61M a year earlier. Total liabilities were $26.85M.

What is Absci's shareholders' equity?

Absci's shareholders' equity was $189.45M as of Dec 31, 2025, or about $1.25 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition